chr6-51616527-A-ATT
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_138694.4(PKHD1):c.*2552_*2553dupAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0147 in 359,846 control chromosomes in the GnomAD database, including 32 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.019 ( 32 hom., cov: 28)
Exomes 𝑓: 0.012 ( 0 hom. )
Consequence
PKHD1
NM_138694.4 3_prime_UTR
NM_138694.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0790
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0187 (2642/141274) while in subpopulation AFR AF= 0.0258 (993/38504). AF 95% confidence interval is 0.0245. There are 32 homozygotes in gnomad4. There are 1225 alleles in male gnomad4 subpopulation. Median coverage is 28. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 32 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKHD1 | NM_138694.4 | c.*2552_*2553dupAA | 3_prime_UTR_variant | 67/67 | ENST00000371117.8 | NP_619639.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKHD1 | ENST00000371117 | c.*2552_*2553dupAA | 3_prime_UTR_variant | 67/67 | 1 | NM_138694.4 | ENSP00000360158.3 | |||
ENSG00000228689 | ENST00000454361.1 | n.81-5814_81-5813dupTT | intron_variant | 3 | ||||||
ENSG00000228689 | ENST00000589278.6 | n.811-5819_811-5818dupTT | intron_variant | 5 | ||||||
ENSG00000228689 | ENST00000650088.1 | n.222-5814_222-5813dupTT | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0187 AC: 2642AN: 141226Hom.: 31 Cov.: 28
GnomAD3 genomes
AF:
AC:
2642
AN:
141226
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0121 AC: 2635AN: 218572Hom.: 0 Cov.: 0 AF XY: 0.0119 AC XY: 1328AN XY: 111144
GnomAD4 exome
AF:
AC:
2635
AN:
218572
Hom.:
Cov.:
0
AF XY:
AC XY:
1328
AN XY:
111144
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0187 AC: 2642AN: 141274Hom.: 32 Cov.: 28 AF XY: 0.0179 AC XY: 1225AN XY: 68410
GnomAD4 genome
AF:
AC:
2642
AN:
141274
Hom.:
Cov.:
28
AF XY:
AC XY:
1225
AN XY:
68410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal recessive polycystic kidney disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at